Brk Monoclonal Antibody

The protein encoded by this gene is a cytoplasmic nonreceptor protein kinase which may function as an intracellular signal transducer in epithelial tissues. Overexpression of this gene in mammary epithelial cells leads to sensitization of the cells to epidermal growth factor and results in a partially transformed phenotype. Expression of this gene has been detected at low levels in some breast tumors but not in normal breast tissue. The encoded protein has been shown to undergo autophosphorylation. Alternative splicing results in multiple transcript variants.

Introducing the BRK Monoclonal Antibody, a cutting-edge biotechnological innovation designed to revolutionize the field of medical research and diagnostics. This highly specialized antibody is meticulously engineered to target and bind to the BRK protein, a key player in various cellular processes and signaling pathways.

The BRK Monoclonal Antibody boasts exceptional specificity and affinity, ensuring precise and reliable detection of the BRK protein in a wide range of biological samples. Its superior performance is attributed to the rigorous selection and optimization process, resulting in a highly purified and concentrated antibody solution.

With its unrivaled sensitivity, the BRK Monoclonal Antibody enables researchers and clinicians to accurately quantify the expression levels of the BRK protein, facilitating a deeper understanding of its role in disease progression and therapeutic response. This invaluable tool empowers scientists to unravel intricate molecular mechanisms and identify potential therapeutic targets for various diseases, including cancer.

Furthermore, the BRK Monoclonal Antibody exhibits exceptional versatility, making it suitable for a multitude of applications, such as Western blotting, immunohistochemistry, and flow cytometry. Its compatibility with diverse experimental techniques ensures seamless integration into existing laboratory protocols, streamlining research workflows and enhancing productivity.

Manufactured under stringent quality control measures, the BRK Monoclonal Antibody guarantees consistent and reproducible results, eliminating any concerns regarding batch-to-batch variability. Its long shelf life and stability further contribute to its reliability, allowing for prolonged usage without compromising performance.

In summary, the BRK Monoclonal Antibody represents a breakthrough in the field of biotechnology, offering researchers and clinicians an indispensable tool for elucidating the intricate workings of the BRK protein. With its exceptional specificity, sensitivity, and versatility, this antibody is poised to drive advancements in medical research and diagnostics, ultimately paving the way for improved patient outcomes and therapeutic interventions.